To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) with progressive disease status.
Stem Cells therapy
European Clinical Trials Information Network
European Clinical Trials Information Network The European Clinical Trials Information Network revolutionizes how patients across Europe access clinical trial information. By eliminating language barriers, our platform ensures that everyone, regardless of their native language, can Read more…
